Alkem Laboratories Q2 Results
- BSE: 539523
- NSE: ALKEM
- ISIN: INE540L01014
- Sector: Biotechnology & Drugs
BSE
5,470.85
-101.10 (-1.81%)
-101.10 (-1.81%)Volume9.05 K
Updated: Mon 25 Nov, 2024 | 15:40:41
NSE
5,478.3-105.05 (-1.88%)
-105.05 (-1.88%)Volume6.07 M
Updated: Mon 25 Nov, 2024 | 15:44:39
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
- Total Income₹3,414.67 Cr.(12.63%)
- Operating Profit₹673.92 Cr.(27.60%)
- Profit After Tax₹688.64 Cr.(26.32%)
- Operating Margin19.74%(0.91%)
Note: Comparison is on YoY basis
Quarterly - Alkem Laboratories Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 24 | Jun 23 | QoQ Comp | Sep 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 3,414.67 | 2,967.72 | -% | 3,440.17 | -% |
| Selling/ General/ Admin Expenses Total | 610.49 | 567.65 | -% | 555.38 | -% |
| Depreciation/ Amortization | 78.91 | 72.41 | -% | 73.90 | -% |
| Other Operating Expenses Total | 846.65 | 812.31 | -% | 810.99 | -% |
| Total Operating Expense | 2,740.75 | 2,650.94 | -% | 2,767.34 | -% |
| Operating Income | 673.92 | 316.78 | -% | 672.83 | -% |
| Net Income Before Taxes | 780.26 | 352.85 | -% | 648.04 | -% |
| Net Income | 688.64 | 286.73 | -% | 620.52 | -% |
| Diluted Normalized EPS | 57.60 | 23.98 | -% | 51.90 | -% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
- Markets
01NTPC Green Energy IPO allotment date likely today. GMP, how to check status online
2 min read07:58 AM IST - Markets
02Buy or sell: Sumeet Bagadia recommends three stocks to buy on Monday — Nov 25
4 min read06:15 AM IST - Markets
03Enviro Infra Engineers IPO day 2: GMP jumps; subscription status, review, apply or not?
3 min read03:07 PM IST